tiprankstipranks
PharmaCielo (TSE:PCLO)
TSXV:PCLO

PharmaCielo (PCLO) Technical Analysis

38 Followers

Summary of all the Indicators

Overall Consensus
Sell
5Bullish
3Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
2Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
1Neutral
11Bearish
PharmaCielo’s (PCLO) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting PharmaCielo is a Buy.
PharmaCielo’s (PCLO) 20-Day exponential moving average is 0.17, while PharmaCielo’s (PCLO) share price is C$0.155, making it a Sell.
PharmaCielo’s (PCLO) 50-Day exponential moving average is 0.18, while PharmaCielo’s (PCLO) share price is C$0.155, making it a Sell.

PharmaCielo (PCLO) Pivot Points

May 19, 2024, 02:56 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.16
0.16
0.16
0.16
0.16
0.16
0.16
Fibonacci
0.16
0.16
0.16
0.16
0.16
0.16
0.16
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

PharmaCielo (PCLO) Moving Averages

May 19, 2024, 02:56 PM
Period
Simple
Exponential
MA5
0.16Neutral
0.16Sell
MA10
0.16Sell
0.16Sell
MA20
0.16Sell
0.17Sell
MA50
0.18Sell
0.18Sell
MA100
0.18Sell
0.18Sell
MA200
0.18Sell
0.18Sell
PharmaCielo’s (PCLO) 10-Day exponential moving average is 0.16, while PharmaCielo’s (PCLO) share price is C$0.155, making it a Sell.
PharmaCielo’s (PCLO) 100-Day exponential moving average is 0.18, while PharmaCielo’s (PCLO) share price is C$0.155, making it a Sell.
PharmaCielo’s (PCLO) stock price is C$0.155 and PharmaCielo’s (PCLO) 50-day simple moving average is 0.18, creating a Sell signal.
PharmaCielo’s (PCLO) stock price is C$0.155 and PharmaCielo’s (PCLO) 100-day simple moving average is 0.18, creating a Sell signal.
PharmaCielo’s (PCLO) stock price is C$0.155 and PharmaCielo’s (PCLO) 200-day simple moving average is 0.18, creating a Sell signal.

PharmaCielo (PCLO) Technical Indicators

May 19, 2024, 02:56 PM
Name
Value
Implied Action
RSI (14)
40.37
Neutral
STOCH (9,6)
>-0.01
Buy
STOCHRSI (14)
7.41
Buy
MACD (12,26)
>-0.01
Buy
ADX (14)
12.22
Buy
Williams %R
-100.00
Buy
CCI (14)
-59.39
Neutral
ATR (14)
0.01
-
Ultimate Oscillator
16.12
Sell
ROC
-8.82
Sell
PharmaCielo’s (PCLO) Relative Strength Index (RSI) is 40.37, creating a Neutral signal.
PharmaCielo’s (PCLO) Trend Strength Indicator (ADX) is 12.22, creating a Buy signal.
PharmaCielo’s (PCLO) Commodity Channel Index (CCI) is -59.39, creating a Neutral signal.
PharmaCielo’s (PCLO) Price Rate of Change (ROC) is -8.82, creating a Sell signal.

FAQ

Is PCLO a Buy, Hold, or Sell?
Based on PCLO’s technical indicators, PCLO is a Sell.
    What is PCLO’s RSI (14)?
    PCLO’s RSI (14) is 40.37, which suggests PCLO is a Neutral.
      What is PCLO’s MACD?
      PCLO’s MACD is >-0.01, which suggests PCLO is a Buy.
        What is PCLO’s 5-day moving average?
        PCLO’s 5-day moving average is 0.15, which suggests PCLO is a Neutral.
          What is PCLO’s 20-day moving average?
          PCLO 20-day moving average is 0.16, which suggests PCLO is a Sell.
            What is PCLO’s 50-day moving average?
            PCLO’s 50-day moving average is 0.18, which suggests PCLO is a Sell.
              What is PCLO’s 200-day moving average?
              PCLO’s 200-day moving average is 0.18, which suggests PCLO is a Sell.
                What is PCLO’s Williams % R (14)?
                PCLO’s Williams % R (14) is -100.00, which suggests PCLO is a Buy.
                  What is PCLO’s CCI (14)?
                  PCLO’s CCI (14) is -59.39, which suggests PCLO is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis